Life-saving
heart attack prevention

Improve patient outcomes with precision coronary imaging to detect high-risk vulnerable plaques.

Octiocor hero image

Accurate, Consistent and Cost Effective.

Mission

Our mission is to prevent heart attacks in high-risk patients through our revolutionary coronary imaging technology.

We aim at providing the best intracoronary imaging (ICI) analysis software.

Offering cutting-edge intracoronary imaging analysis software, our platform is at the forefront of cardiovascular care, dedicated to studying and ultimately preventing heart attacks, in high-risk patients.

Our AI-based software empowers clinicians with comprehensive tools for in-depth analysis, facilitating proactive interventions and personalized treatments that prioritize the long-term well-being of high-risk individuals.

AI-driven technology

We use Optical Coherence Tomography (OCT) images — the highest resolution in-vivo modality — to study atherosclerosis, the disease causing most heart attacks and strokes.

AutoOCT™, our AI-based software, corrects for frequent image artifacts, identifies accurately demarcated tissue interfaces, and measures clinically important lumen and plaque parameters.

Real-time tissue segmentation and measurement identify high-risk vulnerable plaques, guiding evidence-based prophylactic treatment of high-risk patients that improves outcomes.

AutoOCT™ can also be used for clinical trials and research analysis.

Future development will include IVUS and hybrid imaging.

001

OCT Image

Octiocor hero image

002

AutoOCT™ Segmentation

Octiocor hero image

003

AutoOCT™ Stress Map

Octiocor hero image
Octiocor hero image

Lipid

Octiocor hero image

Lumen

Octiocor hero image

Calcium

Octiocor hero image

Thin Fibrous Cap

AI-driven

Leverages a series of deep-learning AI modules to identify, segment and measure different tissue structures in intracoronary OCT images.

Consistent and repeatable

Eliminates well-documented human inter-observer variability when reading OCT images.

Large curated dataset

Trained on the largest known curated dataset of diverse and unselected patients with early and advanced disease states.

Fast and cost effective

Delivers analysis via web interface to clinical trials sponsors in minutes rather than waiting months for human annotation.

0:00   |    0:00

Applications

The AutoOCT™ AI engine segments and measures relevant clinical parameters on all frames in a pullback in real time, including lumen diameters and area, and demarcates the external elastic lamina (EEL). Importantly, AutoOCT™ accurately measures lipid and calcium arc, depth and area, Fibrous Cap Thickness (FCT), and plaque structural stress (PSS), all important features of high risk vulnerable plaques. AutoOCT™ comprehensive output can provide timely information to the cardiologist to guide interventional procedures.

The AutoOCT™ AI engine is the intelligent add-on to any ICI medical device for real time image interpretation and clinical decision support in interventional cardiology.

Octiocor hero image

The AutoOCT™ web-based platform enables data aggregation from different clinical sites where patient pullback images are captured in a secure and timely fashion, protecting patient data confidentiality and streamlining the clinical trial workflow. Once uploaded, each pullback image is analysed with our cutting-edge AI tissue segmenter and required clinical measurements are extracted. Tissue segments and measurements can be visualised immediately on the web-platform. The clinical measurements can be downloaded in a excel or CSV format for subsequent cohort analysis.

The AutoOCT™ web-based platform is the ideal companion for clinical trials and research in the study coronary disease applications for medtech/drug companies, core laboratories and academic researchers.

Octiocor hero image

Our latest news

1 min read   |   August 27, 2024

Octiocor blog image.

A glimpse of our AutoOCT™ web-based platform

This video demo truly brings to life our AI technology. It shows interactively how we segment OCT intracoronary images to automatically identify artery lumen and calcium regions as well as more complex lipid regions and EEL (External Elastic Lamina) to mention a few of the capabilities. The precise segmentation enables us to extract clinically relevant endpoint measurements such as calcium and lipid arcs as well as FCT (Fibrous Cap Thickness) one of the major morphological determinants of plaques to rupture.

Watch the short video demo, it will make things much clearer.

Read full article

1 min read   |   July 16, 2024

Octiocor blog image.

Out of stealth and finally a website

After nearly 2 years in stealth mode with just a placeholder website, the whole team worked really hard to gain the trust of our investors (StartCodon, Cambridge Enterprise, KQ Labs and Ewan Kirk) and funders (BHF and InnovateUK) allowing us further development of our solution. This new website now unveils some of the work we have been up to, more context and news will come over the coming months, so stay tuned.

In the meantime, if you have an interest to know more in partnering or investing, please do not hesitate to reach out on info@octiocor.com.

Read full article

2 min read   |   September 1, 2023

Octiocor blog image.

Octiocor Awarded Advancing Precision Medicine Grant

We are thrilled to announce that Octiocor Ltd has been awarded a highly competitive grant from Innovate UK under its Advancing Precision Medicine initiative. This prestigious recognition not only highlights the groundbreaking work the company is doing at the intersection of artificial intelligence and cardiovascular healthcare but also enables the acceleration of the research & development, regulatory progress, and commercialisation of the AutoOCT™ AI image analysis software for intracoronary artery imaging.

A Leap Forward in Cardiovascular Diagnostics Cardiovascular disease remains the leading cause of mortality globally. Timely and accurate diagnosis is critical to improving patient outcomes. Our proprietary AI software harnesses advanced machine learning and computer vision to analyse intracoronary images with exceptional speed and precision, supporting clinicians in detecting and assessing arterial plaque, stenosis, and other high-risk conditions more effectively. The Innovate UK grant will directly support the next phase of our research and development efforts, which includes:

-Enhancing algorithm accuracy through expanded datasets and continual learning models.

-Scaling clinical validation in collaboration with leading hospitals and research institutions.

-Building robust regulatory and commercial frameworks to bring our solution to market in the UK and internationally.

A Vision for Precision Medicine This funding reflects our commitment to shaping the future of precision medicine where diagnostics are more tailored, intervention is timely, and treatment is data-driven. Our AI solution is designed to integrate into existing catheter lab workflows, where it will deliver real-time analysis that empowers cardiologists to make faster, more informed decisions. “Innovate UK’s support is a game-changer,” said Prof Martin Bennett, CMO and co-founder of Octiocor. “It not only validates the impact of our technology but also propels us closer to our goal of transforming intracoronary diagnostics and improving patient care worldwide.”

Driving Innovation Through Collaboration We extend our thanks to Innovate UK for this opportunity and look forward to deepening our collaborations with NHS partners, academic researchers, and medtech industry leaders. Together, we’re advancing the frontier of cardiovascular AI and bringing cutting-edge technology from the lab to the clinic.

Read full article